The effect of anagliptin on blood glucose and lipid levels in type 2 diabetes mellius
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000012533
- Lead Sponsor
- Yokohama City University Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1)Allergy for vildagliptin, linagliptin, repaglinide and glimepiride severe infection, before operation, severe trauma 2)severe ketosis, diabetic coma within 6 months 3)severe hepatic dysfunction or severe renal dysfunction (SCr:more than 2.0mg/dl or eGFR less than 30) 4)pregnacy 5)Patients judged by the investigator to be ineligible for some other reason
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method